Cryptome CEO resigns

By Melissa Trudinger
Tuesday, 19 October, 2004

Cryptome Pharmaceuticals (ASX: CRP) has announced that CEO Jeffrey Travis has resigned for personal reasons.

US expatriate Travis, who was appointed in January shortly after the company floated on the ASX, is expected to return to the US. The company plans to appoint an interim CEO in the near future.

Anti-inflammatory drug may help treat alcohol use disorder

A drug that is already FDA-approved for treating inflammatory conditions may help reduce both...

Osteoarthritis study uncovers new genetic links, drug targets

The genome-wide association study (GWAS) uncovered over 900 genetic associations, more than 500...

How brain cells are affected by Tourette syndrome

US researchers have conducted a cell-by-cell analysis of brain tissue from individuals with...

Content from other channels on our network

PE20 Palletising System by Optima Robotics

Snackfood development: protein puffs that are easy to swallow

China's new food colouring standard welcomed by industry

Bega to close Strathmerton cheese processing plant by mid-2026

Fonterra invests a further $70m to move away from coal

Tallawang Solar Hybrid project secures access rights

CSIRO announces ON Accelerate project teams

SEW Water Saver App recognised as awards finalist

How AI-powered bushfire detection can protect forests and communities

Industrias partners with Microgrid Power to maintain solar

Long-duration battery technologies crucial for a clean energy future: UNSW

Bega Group to close Victorian cheese factory

Engineers Australia appoints new Chief Engineer

South Australia’s exports to the EU hit $1 billion

Incat launches the world’s largest battery‍-‍electric ship